The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Influenza
Interventions
BIOLOGICAL

Live attenuated influenza vaccine (LAIV4)

LAIV4 vaccine dosage is 0.2 mL. The vaccine will be administered as an intranasal spray. Each sprayer contains a single dose of FluMist® Quadrivalent; approximately one-half of the contents should be administered into each nostril. 0.1 mL (i.e., half of the dose from a single FluMist sprayer) is administered into each nostril while the recipient is in an upright position. Insert the tip of the sprayer just inside the nose and rapidly depress the plunger until the dose-divider clip stops the plunger. The dose-divider clip is removed from the sprayer to administer the second half of the dose (0.1 mL) into the other nostril.

BIOLOGICAL

Inactivated Influenza Vaccine (IIV4)

IIV4 vaccine will be administered as a 0.5 mL dose, with a sterile, disposable syringe and needle by IM injection.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT03898986 - The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets | Biotech Hunter | Biotech Hunter